Adil Daud

MD

Oncologist and melanoma specialist
Immunotherapy researcher, history and literature buff

About me

Dr. Adil Daud, an oncologist, specializes in melanoma and other skin cancers. He is co-director of the Melanoma Center. In addition to caring for patients, he directs research to better understand the biology of melanoma and to develop new treatments. He has developed and led many clinical trials that have expanded the use of gene therapy for melanoma.

Daud earned a medical degree at the Government Medical College, Nagpur. He completed both an internship and a residency in internal medicine at Indiana University School of Medicine, followed by a fellowship in hematology-oncology at Memorial Sloan Kettering Cancer Center. Prior to joining UCSF Medical Center, he was a researcher at the Moffitt Cancer Center in Tampa, Florida, for seven years.

Daud has won numerous awards, including a Young Investigator Award from the American Society of Clinical Oncology and selection as a Castle Connolly Top Doctor.

  • Education

    Government Medical College, Nagpur, 1986

  • Residencies

    Indiana University School of Medicine, 1997

  • Fellowships

    Memorial Sloan-Kettering Cancer Center, 2000

  • Board Certifications

    Internal Medicine, American Board of Internal Medicine

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Professor

  • Languages

    Hindi

The future of cancer therapy is here, and it is immunotherapy. And it arrived a lot sooner than expected!

Conditions I specialize in

Melanoma & Skin Cancer Program

Bakar Precision Cancer Medicine Building

1825 Fourth Street, Third Floor
San Francisco, CA 94158

(415) 353-7817

My reviews

4.8

Overall Experience
292 Reviews
Dr Daud has been the best doctor we've ever experienced in every way. We feel incredibly blessed to have him as our doctor.
Explained things in a way that was easy to understand
292 Reviews
Did the doctor pay attention to your concerns
292 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
275 Reviews
Knew the important information about your medical history
288 Reviews
The provider showed respect for what you had to say
289 Reviews
The provider spent enough time with me
287 Reviews
Read all reviews About our process

Selected research

Decorative Caduceus

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Defined as the proportion of subjects for whom the best overall response at the time of data cutoff is confirmed complete response (CR) or partial response (PR) as per Response Evaluation Criteria in Solid Tumors (RECIST). Point e...

Recruiting

Decorative Caduceus

A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Vers...

Recruiting

Decorative Caduceus

Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Tr...

ORR defined as the proportion of patients with a best overall response of either confirmed complete response or confirmed partial response (as per local review and according to RECIST v1.1)

Recruiting

Decorative Caduceus

A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma

Recruiting

Decorative Caduceus

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Treatment-related adverse events as assessed by CTCAE v4.03

Recruiting

My work

Advanced skin cancer was once a death sentence. Immunotherapy Is changing that.

Contact me

Providers on my team

Share